Atlas Merchant Capital LLC acquired a new position in iCoreConnect Inc. (NASDAQ:FGMC – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 261,000 shares of the company’s stock, valued at approximately $2,714,000. Atlas Merchant Capital LLC owned approximately 2.57% of iCoreConnect at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. Exos TFP Holdings LLC grew its position in iCoreConnect by 2.9% during the fourth quarter. Exos TFP Holdings LLC now owns 74,787 shares of the company’s stock valued at $762,000 after purchasing an additional 2,078 shares in the last quarter. Deutsche Bank AG acquired a new position in shares of iCoreConnect in the fourth quarter worth $44,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in shares of iCoreConnect in the first quarter worth $521,000. Wolverine Asset Management LLC boosted its position in iCoreConnect by 16.8% during the first quarter. Wolverine Asset Management LLC now owns 419,461 shares of the company’s stock valued at $4,362,000 after purchasing an additional 60,386 shares during the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new position in iCoreConnect in the 2nd quarter worth about $3,526,000. 70.69% of the stock is currently owned by institutional investors and hedge funds.
iCoreConnect Stock Down 5.2 %
Shares of iCoreConnect stock traded down $0.34 during trading on Friday, hitting $6.16. 1,291,133 shares of the stock traded hands, compared to its average volume of 35,996. The company has a fifty day moving average price of $9.56 and a two-hundred day moving average price of $10.15. iCoreConnect Inc. has a twelve month low of $4.48 and a twelve month high of $12.35.
iCoreConnect Profile
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Featured Stories
- Five stocks we like better than iCoreConnect
- How to Invest in Apparel Stocks
- MarketBeat Week in Review – 9/4 – 9/8
- How to Start Investing in Penny Stocks
- The Best 5 Small Cap AI Companies to Buy Now
- How to Invest in Grocery Stores
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.